Display options
Cite
Jian ZH, Lung CC, Huang JY, et al. Sex disparities in the association of lung adenocarcinoma with colorectal cancer. J Cancer. 2013;4(9):691-6doi: 10.7150/jca.7269.
Jian, Z. H., Lung, C. C., Huang, J. Y., Su, S. Y., Ho, C. C., Chiang, Y. C., & Liaw, Y. P. (2013). Sex disparities in the association of lung adenocarcinoma with colorectal cancer. Journal of Cancer, 4(9), 691-6. https://doi.org/10.7150/jca.7269
Jian, Zhi-Hong, et al. "Sex disparities in the association of lung adenocarcinoma with colorectal cancer." Journal of Cancer vol. 4,9 (2013): 691-6. doi: https://doi.org/10.7150/jca.7269
Jian ZH, Lung CC, Huang JY, Su SY, Ho CC, Chiang YC, Liaw YP. Sex disparities in the association of lung adenocarcinoma with colorectal cancer. J Cancer. 2013 Nov 02;4(9):691-6. doi: 10.7150/jca.7269. eCollection 2013. PMID: 24312138; PMCID: PMC3842437.
Copy Download .nbib Format: NLM
Share it on

J Cancer. 2013 Nov 02;4(9):691-6. doi: 10.7150/jca.7269. eCollection 2013.

Sex disparities in the association of lung adenocarcinoma with colorectal cancer.

Journal of Cancer

Zhi-Hong Jian, Chia-Chi Lung, Jing-Yang Huang, Shih-Yung Su, Chien-Chang Ho, Yi-Chen Chiang, Yung-Po Liaw

Affiliations

  1. 1. Department of Public Health and Institute of Public Health, Chung Shan Medical University, Taichung City 40201, Taiwan;

PMID: 24312138 PMCID: PMC3842437 DOI: 10.7150/jca.7269

Abstract

BACKGROUND: Most cancers share common risk factors. It might provide evidence of shared risk factors with cancers by investigating cross-country and cross-township comparisons.

METHODS: The data were obtained from International Association of Cancer Registries/World Health Organization and the National Cancer Registration Program of Taiwan. Age standardized incidence rates were calculated among gastric cancer, colorectal cancer and lung adenocarcinoma in 19 countries from 1995 to 1998. The Pearson correlations were also compared among 3 types of cancers for both sexes.

RESULTS: The incidence rates of gastric and colorectal cancer throughout different countries show male dominance with a male-to-female sex ratio of around 2 and 1.5, respectively. Significant cross-country correlations in colorectal cancer (r=0.918, p<0.001), gastric cancer (r=0.985, p<0.001) and lung adenocarcinoma (r=0.685, p=0.001) were observed between men and women. There was a significant international correlation between colorectal cancer and lung adenocarcinoma in men (r=0.526, p=0.021), but not in women. In cross-township comparisons of Taiwan, there were significant correlations in colorectal cancer (r=0.451, p<0.001), gastric cancer (r=0.486, p<0.001), and lung adenocarcinoma (r=0.217, p<0.001) between men and women. There were links of lung adenocarcinoma and gastric cancer (r=0.122, p=0.024) and colorectal cancer (r=0.128, p=0.018) in women, and lung adenocarcinoma and colorectal cancer in men (r=0.276, p<0.001).

CONCLUSIONS: There were associations between lung adenocarcinoma and colorectal cancer between and in both sexes in Taiwan, but not in cross-country comparisons. The results suggest that some factor, like genes, may be important as determinants for the association between lung adenocarcinoma and colorectal cancer.

Keywords: Colorectal cancer; Lung adenocarcinoma; Pearson correlation.

References

  1. Gastroenterology. 2010 Jun;138(6):2029-2043.e10 - PubMed
  2. Int J Colorectal Dis. 2012 Mar;27(3):345-53 - PubMed
  3. Int J Cancer. 2012 May 15;130(10):2387-96 - PubMed
  4. Onco Targets Ther. 2013;6:135-43 - PubMed
  5. Cancer Causes Control. 2008 Sep;19(7):689-701 - PubMed
  6. J Clin Oncol. 2009 Sep 20;27(27):4542-7 - PubMed
  7. Clin Gastroenterol Hepatol. 2011 Feb;9(2):137-44 - PubMed
  8. J Natl Cancer Inst. 2007 Nov 21;99(22):1729-35 - PubMed
  9. J Natl Cancer Inst. 2005 Mar 2;97(5):339-46 - PubMed
  10. Lung Cancer. 2005 Mar;47(3):325-36 - PubMed
  11. Am J Gastroenterol. 2008 Jun;103(6):1488-95 - PubMed
  12. Cancer Res. 2008 Apr 15;68(8):3037-42 - PubMed
  13. J Surg Oncol. 2012 Sep 15;106(4):456-61 - PubMed
  14. J Clin Epidemiol. 2003 Jan;56(1):1-9 - PubMed
  15. Cancer Metastasis Rev. 2010 Mar;29(1):37-48 - PubMed
  16. Clin Lung Cancer. 2012 Mar;13(2):143-8 - PubMed
  17. BMC Cancer. 2011 Sep 26;11:409 - PubMed
  18. Eur J Cancer. 2001 Sep;37 Suppl 4:S9-15 - PubMed
  19. Jpn J Clin Oncol. 2010 Oct;40(10):897-904 - PubMed
  20. Nat Rev Cancer. 2005 May;5(5):341-54 - PubMed
  21. Br J Cancer. 2009 May 5;100(9):1483-5 - PubMed
  22. Eur J Cancer Prev. 2002 Feb;11(1):27-38 - PubMed
  23. J Clin Endocrinol Metab. 2012 Jul;97(7):E1170-5 - PubMed
  24. Arch Physiol Biochem. 2009 May;115(2):86-96 - PubMed
  25. Eur J Cancer Prev. 1998 Dec;7(6):473-8 - PubMed
  26. Clin Cancer Res. 2007 Jun 15;13(12):3597-604 - PubMed
  27. Int J Clin Oncol. 2014 Apr;19(2):303-11 - PubMed
  28. Am J Clin Oncol. 2015 Apr;38(2):147-51 - PubMed
  29. J Cancer. 2012;3:137-44 - PubMed
  30. Crit Rev Oncol Hematol. 1995 Jul;19(3):183-232 - PubMed
  31. Metabolism. 2012 Feb;61(2):242-9 - PubMed
  32. Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):20-38 - PubMed
  33. Clin Cancer Res. 2004 Dec 15;10(24):8195-203 - PubMed
  34. Lung Cancer. 1999 Jun;24(3):149-55 - PubMed
  35. Jpn J Clin Oncol. 1996 Aug;26(4):229-33 - PubMed
  36. Cancer. 2007 Oct 15;110(8):1768-75 - PubMed
  37. Tumour Biol. 2010 Jan;31(1):16-22 - PubMed
  38. Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):725-31 - PubMed

Publication Types